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PAX6 Expression and Retinal Cell Death in a Transgenic
Mouse Model for Acute Angle-Closure Glaucoma
Dinu Stanescu-Segall, MD,* Kerstin Birke, PhD,w Andreas Wenzel, PhD,z Christian Grimm, PhD,z
Sorguel Orgul, MD, PhD,y Jan A. Fischer, PhD,w Walter Born, PhD,w and Farhad Hafezi, MD, PhDJ
Purpose: PAX6 is a highly conserved protein essential for the
control of eye development both in invertebrates and vertebrates.
PAX6 expression persists in the adult inner retina, but little is
known about its functions after completion of retinal diﬀerentia-
tion. Therefore, we investigated PAX6 expression in wild-type and
calcitonin receptor-like receptor transgenic (CLRSMaA) mice with
angle-closure glaucoma.
Methods: Intraocular pressure was measured by indentation
tonometry in anesthetized mice. Eyes of mice of both genotypes
were enucleated at various ages and retinas were processed for
morphological analysis and PAX6 immunostaining. The content of
PAX6 in retinal extracts was estimated by Western blot analysis.
Retinal expression of glaucoma-related genes was analyzed by
reverse transcription-polymerase chain reaction.
Results: Control mice showed normal retinal morphology between
p22 and p428 with steady PAX6 expression in the ganglion cell
layer (GCL) and the inner nuclear layer (INL). CLRSMaA mice
examined between p22 and p82 exhibited increased intraocular
pressure and a progressive decrease in cell number including PAX6-
expressing cells in the GCL. The INL was not aﬀected up to
postnatal day 42. Later, a signiﬁcant increase in PAX6-expressing
cells concomitant with an overall loss of cells was observed in the
INL of CLRSMaA as compared with control mice. Retinal up-
regulation of glaucoma-related genes was furthermore observed.
Conclusions: Distinctive changes of PAX6 expression in the inner
retina of CLRSMaA mice suggest a role in regulatory mechanisms
involved in glaucoma-related retinal cell death. The selective
increase of PAX6 expression in the degenerating INL of CLRSMaA
mice may represent an attempt to preserve retinal cytoarchitecture.
Key Words: PAX6, human, angle-closure, glaucoma, retinal
degeneration, ganglion cells
(J Glaucoma 2015;00:000–000)
PAX6, a member of the paired box family of transcrip-tion factors, is an essential control gene for eye
morphogenesis both in invertebrates and vertebrates.1–3
Its importance for eye development was demonstrated in
several species. The human and murine (small eye) PAX6
protein are identical in their amino acid sequence, and the
Drosophila homolog (Eyeless) shows over 90% identity
over the paired and the homeodomain.4 Moreover, gain-of-
function studies demonstrated that targeted expression of
Drosophila and PAX6 induces ectopic eyes in Drosophila.5
Mutations in PAX6 lead to a variety of eye
abnormalities including hereditary foveal hypoplasia, optic
nerve malformation, and aniridia in mice6–9 and hu-
mans.10–18
PAX6 has been studied extensively in eye and retinal
development. Normal development of the inner retina
is directly inﬂuenced by a well-elaborated spatial and
temporal pattern of PAX6 expression.1,6–9,19–21 However,
little is known about PAX6 expression and function in the
adult mammalian retina. De Melo et al22 showed that
several homeobox genes including Pax6 are expressed in
the young adult mouse retina and we recently reported
continuous expression of PAX6 in the young, adult, and
old normal human retina.23
To investigate the role of PAX6 expression in the adult
eye and to assess whether PAX6 is involved in degenerative
processes of the retina, we studied PAX6 expression in wild
type and in calcitonin receptor-like receptor transgenic
(CLRSMaA) mice with acute angle-closure glaucoma
(ACG).24
MATERIALS AND METHODS
All animal experiments conformed to the guidelines of
the Veterinary Authorities of the Kanton of Zurich and to
the statement of the Association for Research in Vision and
Ophthalmology for the use of Animals in Ophthalmic and
Vision Research.
Animals
CLRSMaA mice were generated and genotyped to-
gether with wild-type littermates as reported.24 Three
CLRSMaA mice and 3 control littermates were analyzed at
indicated ages in individual experiments. Animals were
sacriﬁced by cervical dislocation and experiments were
performed in triplicates.
Measurement of Intraocular Pressure
Intraocular pressure (IOP) was measured by indenta-
tion tonometry in anesthetized mice as described pre-
viously.24 An average of 6 readings was considered as a
single result; presented values are the average of 10 eyes per
genotype at each time point (same mice at diﬀerent ages).
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Retinal Morphology
Eyes were prepared as described previously.25 Brieﬂy,
mice were sacriﬁced and enucleated eyes were ﬁxed with
2.5% glutaraldehyde in 0.1M cacodylate buﬀer, pH 7.3, at
41C overnight. The eyes were then washed in cacodylate
buﬀer, incubated in osmium tetroxide for 1 hour, dehy-
drated in ascending ethanol series, and embedded in Epon
812 (Sigma-Aldrich, St. Louis, MO). Central retinal sections
(0.5mm; temporal-nasal) were stained with toluidine blue
(Sigma-Aldrich, St. Louis, MO) and analyzed by light
microscopy.
Retinal Morphometry
CLRSMaA and control mice were sacriﬁced and the
eyes were enucleated and ﬁxed by immersion in 4%
paraformaldehyde in phosphate-buﬀered saline overnight.
The eyes were then dehydrated and embedded in paraﬃn
according to standard protocols. Paraﬃn sections (5 mm)
were deparaﬃnized in xylene, hydrated in descending
ethanol series, and stained with toluidine blue. The sections
were then washed with water, dehydrated in ethanol, and
mounted with DPX (Sigma-Aldrich, St. Louis, MO).
Morphometry in the ganglion cell layer (GCL) and inner
nuclear layer (INL) of CLRSMaA and control littermates
was performed by counting all cells in the respective layers
on 5 mm central sagittal sections under the microscope at
40-fold magniﬁcation with the ImageJ software (http://
rsb.info.nih.gov/ij/; version 1.36a). Data were collected
from 3 sections per eye of 3 CLRSMaA and 3 age-matched
control littermates.
Retinal Immunohistochemistry
Central sagittal sections were boiled at 951C for 20
minutes in citrate buﬀer and incubated in blocking reagent
(Vector Laboratories, Burlingame, CA) at room tempera-
ture for 60 minutes. The sections were then incubated at
41C overnight with polyclonal rabbit antibodies to PAX6
(1:300) (Chemicon, Temecula, CA). PAX6 immunostaining
was visualized with secondary biotinylated antibodies to
rabbit IgG (1:200) (Vector Laboratories, Burlingame, CA)
and Cy3-labeled streptavidin (1:200) (Sigma-Aldrich, St.
Louis, MO). Fluorescence was detected with a DX20 CCD
camera (Kappa, Gleichen, Germany) connected to a 0.45
projection lens of an Eclipse E600 Nikon microscope
equipped with a Plan Fluor 20 /0.5 DLL objective and a
G-2A (Cy3) ﬁlter block.
Western Blot Analysis
Retinas were rapidly dissected through a slit in the
cornea using the Winkler technique.26 The tissue was
sonicated in 100mM Tris/HCl, pH 7.5, containing com-
plete protease inhibitor cocktail tablets (Roche Diagnostics,
Rotkreuz, Switzerland). Retinal extracts were cleared by
centrifugation and proteins were separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (12%)
and then electrotransfered to nitrocellulose Hybond en-
hanced chemiluminescent membranes (GE Healthcare
Europe GmbH, Otelﬁngen, Switzerland) in a Trans-Blot
SD semi-dry transfer cell (Bio-Rad Laboratories, Hercules,
CA). The membranes were blocked with 5% low fat milk.
PAX6 was detected with corresponding polyclonal anti-
bodies (1:5000) (Chemicon, Temecula, CA) and alkaline
phosphatase-conjugated secondary antibodies (1:15,000)
(Sigma-Aldrich, St. Louis, MO). PAX6 was normalized to
actin as a protein loading control. Actin was detected with
mouse monoclonal antibodies to actin (1:5000) (Sigma,
Buchs, Switzerland) and alkaline phosphatase-conjugated
secondary antibodies (1:15,000) (Sigma-Aldrich, St. Louis,
MO). Alkaline phosphatase activity was visualized with the
Bio-Rad detection kit (Bio-Rad Laboratories, Hercules,
CA) and a VersaDoc Imaging System (Bio-Rad Labora-
tories, Hercules, CA).
Reverse Transcription and Semi-quantitative
Polymerase Chain Reaction
Retinas were prepared from CLRSMaA mice and
control littermates as described above and frozen in liquid
nitrogen. Total RNA was isolated with the RNeasy kit
(QIAGEN, Hilden, Germany) and cDNA was generated
with Moloney Murine leukemia virus reverse transcriptase
(Promega, Madison, WI). Polymerase chain reaction was
carried out with primers speciﬁc for glial ﬁbrillary acidic
protein (GFAP) (forward: 50-CCACCAAACTGGCTGA
TGTCTAC-30, reverse: 50-TTCTCTCCAAATCCACACGA
GC-30); tissue inhibitors of metalloproteinase-1 (TIMP-1)
(forward: 50-AGAAATCAACGAGACCACCT-30, reverse: 50-
GGGCTCAGAGTACGCCA-30); interleukin-1b (IL-1b) (for-
ward: 50-GCAGGCAGTATCACTCATTG-30, reverse: 50-CG
TTGCTTGGTTCTCCTTGT-30); Endothelin-2 (forward: 50-
TTGTGAGTGCTCTACTGCG-30, reverse: 50-GGTGTTATC
TCTTCCTCCATCT-30); X-linked inhibitor of apoptosis
(XIAP) (forward: 50-GGATCCTCTGATGCTGTGAGTTCT
GATAGGAATTTCCC-30, reverse: 50-GACTCGAGCTAAG
TAGTTCTTACCAGACACTCCTCAAG-30); Bcl-XL (for-
ward: 50-GACTTTCTCTCCTACAAGC-30, reverse: 50-CG
AAAGAGTTCATTCACTAC-30); Bcl-2 (forward: 50-TTG
TGGCCTTCTTTGAGTTCG-30, reverse: 50-ATTTCTACTG
CTTTAGTGAACC-30); and glyceraldehyde 3-phosphate dehy-
drogenase (forward: 50-GGGTGGAGCCAAACGGGTC-30,
reverse: 50-GGAGTTGC-TGTTGAAGTCGCA-30) with Roche
LightCycler reagents. Polymerase chain reaction products were
separated and quantiﬁed on agarose gels by densitometry.
Statistical Analysis
Results are presented as the mean±standard error of
the mean. Diﬀerences between mean values were analyzed
by analysis of variance using the Prism 3.0 software
(GraphPad Software Inc, San Diego, CA). P<0.05 was
considered statistically signiﬁcant.
RESULTS
PAX6 is Expressed in the Inner Retina
Throughout the Lifespan of Wild-type Mice
Retinal morphology and PAX6 expression were
examined in wild-type mice at postnatal days (p) 5, 9, 15,
20, 24, 29, 243, and 428. Retinal morphology was normal in
all mice analyzed (Fig. 1A, representative retinal section at
p29). PAX6 expression was conﬁned mainly to nuclei of
cells in the inner part of the INL and, to a lesser extent, to
the GCL at all time points tested (Fig. 1B, representative
section at p29). Western blot analysis showed continuous
expression of PAX6 from p5 to p428 with a minimal
decrease between p5 and p20 (Fig. 1C).
Retinal Damage in CLRSMaA Mice With Increased
Ocular Pressure
CLRSMaA mice presented normal IOP at the end of
ocular development on p20 (Fig. 2A). Subsequently, the
IOP increased up to p62 to over 2-time higher levels than in
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control mice. Consequently, the number of apoptotic
terminal deoxynucleotidyl transferase dUTP nick end
labeling-stained cells in the GCL of CLRSMaA mice was
higher than in control animals (not shown). Moreover, the
expression of genes indicating gliosis or apoptosis of the
glaucomatous retina was also altered in CLRSMaA mice
(Table 1). On p32, the gliosis-related GFAP and endothe-
lin-2 gene-derived transcripts were found up-regulated in
FIGURE 1. PAX6 expression in the retina of wild-type mice. Morphological analysis at p29 shows normal cytoarchitecture of the outer
and inner retina (Epon embedding, methylene blue staining) (A). Immunohistochemical PAX6 staining at p29 revealed PAX6 expression
confined to the nuclei of the inner nuclear layer (INL) and the ganglion cell layer (GCL) (arrows) (B). The rod inner segments (RIS) and
the outer nuclear layer (ONL) are also shown. Western blot analysis of PAX6 expression in the retina of mice at indicated ages (C). Equal
amounts of protein were loaded. p29 indicates postnatal day 29.
FIGURE 2. Increase in IOP over time in CLRSMaA mice () as compared with control littermates (*) (A). Data are mean (±SEM) of IOP
measurements in at least 10 CLRSMaA and 10 control mice per time point. Morphology of the ganglion cell layer (GCL), the inner nuclear
layer (INL), and the outer nuclear layer (ONL) in representative 5-mm toluidine blue-stained central sagittal sections of the retina of
CLRSMaA and control (wild-type) mice at indicated ages (B). Morphometric analysis of the GCL and the INL in control (open bars) and
CLRSMaA mice (closed bars) at indicated ages (C). Data are mean±SEM of 3 sections per eye from 3 controls and 3 CLRSMaA mice per time
point. IOP indicates intraocular pressure; SEM, standard error of mean.
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CLRSMaA as compared with control animals. Endothelin-2,
unlike GFAP transcripts, remained up-regulated on p82.
The TIMP-1 encoding transcripts, similar to those for
endothelin-2, were up-regulated on p32 and p82. Consistent
with the ongoing apoptosis in the retina of CLRSMaA mice,
IL-1b transcripts were up-regulated on p32 and p82, and
XIAP transcripts and those encoding the anti-apoptotic
proteins Bcl-XL and Bcl-2 were lower than in control mice
on p82.
Retinal morphology was normal in CLRSMaA mice at
p22 (Figs. 2B, C). Subsequently, the number of cells in the
GCL of CLRSMaA mice decreased more rapidly than in
control littermates. The INL, on the other hand, showed
similar and unchanged morphological and morphometric
features in control and CLRSMaA mice up to p42. At p82,
however, the cell number in the INL was signiﬁcantly lower
(P<0.05) in CLRSMaA than in control mice.
PAX6 Expression in the Retina of CLRSMaA Mice
PAX6 expression in the retina of CLRSMaA mice and
control littermates was conﬁned to the nuclei of the INL
and GCL (Fig. 3A). In CLRSMaA mice, unlike in control
littermates, the number of PAX6-expressing cells in the
GCL decreased in parallel to the total number of cells
between p22 and p82 (Fig. 2C, Fig. 3B). In the INL, on the
other hand, the number of PAX6-expressing cells was
indistinguishable in CLRSMaA and control mice up to p42,
but, interestingly, on p82 the number of PAX6-expressing
cells was signiﬁcantly (P<0.05) higher in CLRSMaA than in
control mice (Fig. 3). These morphometric and immuno-
histochemical results were consistent with transiently
decreased levels of PAX6 on p42, p52, and p62 and
subsequently increased levels on p72, reaching a peak at
p82 and being sustained at higher levels until p102 in total
retinal extracts of CLRSMaA as compared with control
mice, recognized on Western blots (Fig. 4).
DISCUSSION
PAX6 is a transcription factor inﬂuencing eye mor-
phogenesis in invertebrates and vertebrates.2,3 Besides the
striking amino acid sequence similarities of PAX6 in
diﬀerent species, conserved regulation of expression seems
to be vital for ocular integrity.27 Although PAX6 was
extensively studied during eye organogenesis in various
species, little is known about PAX6 expression and function
in adult eye tissues. PAX6 expression in the GCL and INL
of the inner retina was observed in humans,23 chicken,28
and mouse29 and Zhang et al30 detected PAX6 expression in
the adult lens epithelium.
TABLE 1. Relative Expression Levels of Apoptosis-related Gene
Transcripts Determined by Reverse Transcription-polymerase
Chain Reaction in Retinal RNA Extracts of CLRSMaA Compared
With Control Mice
mRNA p32 p82
GFAP 2.95 0.78
TIMP-1 16.85 24.53
IL-1b 1.69 1.47
Endothelin-2 11.45 17.98
XIAP 0.96 0.29
Bcl-XL 1.20 0.69
Bcl-2 1.02 0.42
Bcl-2 indicates B-cell leukemia/lymphoma-2; Bcl-XL, B-cell leukemia/
lymphoma extra long; GFAP, glial ﬁbrillary acidic protein; IL-1b,
interleukin-1b; TIMP-1, tissue inhibitor of metalloproteinase-1; XIAP,
X-linked inhibitor of apoptosis.
FIGURE 3. PAX6 expression in the ganglion cell layer (GCL) and the inner nuclear layer (INL) in control (wild-type) and CLRSMaA mice
(A). Immunofluorescent staining of PAX6 (red, arrowheads) and 40,60 -diamidino-2-phe´nylindole staining of cell nuclei (blue) in the GCL
and the INL of central retinal sections also including the outer nuclear layer (ONL) on p82. B, Morphometric analysis of PAX6 expression
over time in the GCL and the INL from control (open bars) and CLRSMaA (closed bars) mice. Data are mean±SEM of 3 sections per eye
from 3 control and 3 CLRSMaA mice per time point. *P < 0.05 compared with control mice of the same age. p82 indicates postnatal day
82; SEM, standard error of mean.
Birke et al J Glaucoma  Volume 00, Number 00, ’’ 2015
4 | www.glaucomajournal.com Copyright r 2015 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of the article is prohibited.
To further elucidate the potential roles of PAX6 in the
inner retina of an adult eye, we investigated its expression in
wild-type and CLRSMaA mice, a mouse model of acute
ACG. ACG is very much underestimated and suspected to
aﬀect half of all glaucoma patient worldwide and accounts
for 91% of bilateral glaucoma blindness in China.31 ACG
pathophysiology is largely unknown and CLRSMaA mouse
model appears as a reliable mouse model for this disease.
It oﬀers the advantage to mimic human condition with
transient IOP peaks between 1 and 3 months.24 It obviates
repetitive manipulations on the eyes of the mouse and costly
equipment such as lasers needed for laser-induced increased
IOP models.32–34 It is also one of the few genetic rodent
model that is amendable to experimental manipulation
because of its shorter course of glaucomatous pathology.
These mice develop ACG after completion of retinal
development24 and, as shown here, suﬀer from progressive
retinal ganglion cell loss.
The retina of CLRSMaA mice expressed elevated levels
of GFAP, TIMP-1, IL-1b, and endothelin-2, which were
also found to be up-regulated in glaucoma in previous
studies. Increased GFAP is commonly observed in degen-
erative retinal diseases,35,36 whereas TIMP-1–encoding
mRNA is elevated in microglia of glaucoma patients.37
Activation of proinﬂammatory IL-1b might be involved in
the etiology of glaucoma35,38,39 and increased endothelin-2
expression occurs in human glaucoma during glial activa-
tion.40 Late down-regulation of the caspase inhibitor XIAP
and of Bcl-XL and Bcl-2 was observed in CLR
SMaA mice on
p82, similar to observations in degenerating retinas.41–43 As
transgenic expression of XIAP was shown to increase
survival of cells in the inner retina in mouse models of
ischemia,44 it seems likely that the reduced expression of
this inhibitor of apoptosis contributes to the retinal
pathology and the observed loss of neuronal cells.
Our results also show a decreased PAX6 expression in
the GCL of CLRSMaA mice during the initial phase of
ganglion cell degeneration. At p82, however, cells of the
INL in CLRSMaA mice displayed a marked increase in
PAX6 protein levels. At this time point, the GCL has lost
about 75% of its cells (Fig. 2) and thus synaptic
connectivity between bipolar, amacrine, and ganglion cells
was severely disrupted. We found similar results in total
protein extracts of CLRSMaA mice. Western blots of PAX6
showed an increase of its expression at p72, reaching a peak
at p82, with a progressive decline from p92 until normal
levels at p102.
In DBA/2J mouse, peak of retina ganglion cell (RGC)
apoptosis varies between 6 and 11 months according to
Schuettauf et al and Libby et al.45,46 We speculate that in
this mouse, PAX6 expression would have increased after
the peak of GCL apoptosis. Although the length of time
needed to obtain these results in DBA/2J was too long to be
able to verify our hypothesis.
In laser-induced ocular hypertension mouse model of
glaucoma, IOP is less elevated than in CLRSMaA mice and
induce a moderate RGC reduction of 15% to 17% and
22% to 27% after 2 and 4 weeks, respectively after laser
photocoagulation of the episcleral and limbal veins.32,33 We
believe that in this mice, a slight elevation of PAX6
expression would have occurred after 4 weeks but probably
less pronounced than in our model because the apoptosis
peak was less marked. Unfortunately, the cost of laser
equipment precludes us from corroborating these data. We
were less interested in studying PAX6 expression in RGC
death after mechanical injury of the optic nerve,47
intraocular injection of excitotoxic agents,48,49 or by the
induction of ischemia followed by reperfusion50 because the
pathophysiology in those systems does not directly follow
that of human glaucoma.
It has been shown in models of photoreceptor
degeneration that cells especially of the INL react to loss
of neurons by the induction of a program leading to retinal
remodeling (for review see Ref. 51). During the initial phase
of photoreceptor loss, bipolar and horizontal cells are
deaﬀerented and retract most of their dendrites, and Muller
cells increase the production of intermediate ﬁlaments.
Although remodeling processes in models of glaucoma have
not been studied in detail, Marc and coworkers51 showed
that the space left by degenerated ganglion cells in retinitis
pigmentosa retinas was ﬁlled at least in part by Muller cell
end feet. Interestingly, Jones and coworkers have demon-
strated that PAX6 expression is increased in cells of the
INL during retinal degeneration in the rd1 mouse,29
concomitantly with the early phase of remodeling pro-
cesses. As PAX6 regulates eye development including
retinal morphogenesis,52 it is conceivable that increased
PAX6 production during degeneration is required for
surviving cells to adapt to the altered conditions by
changing their cytoarchitecture. This is supported by
observations that expression levels of PAX6 can severely
inﬂuence the overall ocular structure. In the mouse eye for
example, PAX6 overexpression leads to severe abnormal-
ities such as microphthalmia and cataract formation53 and
FIGURE 4. PAX6 expression over time was examined by Western blot analysis in retinal extracts of control (wild-type) and CLRSMaA
mice. PAX6 and actin were visualized by enhanced chemiluminescence with corresponding antibodies. Representative for 3
independent experiments (A). Relative changes of PAX6 expression normalized to actin in the retina of CLRSMaA compared with control
mice (B). The values obtained for the extracts of control mice at individual time points were set to 100%. Data are the mean ± SEM of 3
independent experiments. *P < 0.05 compared with control mice of the same age. Open bars refer to expression of control mice and
closed bars refer to CLRSMaA mice. SEM indicates standard error of mean.
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Glaser et al54 have clearly shown a gene dosage eﬀect of
PAX6 in a human family in which diﬀerent members were
aﬀected by PAX6 mutations with either full or only partial
transcriptional activity.
Taken together, our data show that retinal ganglion
cell death induces the expression of PAX6 in cells of the
INL. This suggests that PAX6 might be involved in the
maintenance of the cellular integrity after the loss of
synaptic connectivity and/or in processes required for the
remodeling of the retinal cytoarchitecture after ganglion
cell loss. Further studies looking at PAX6 expression in
other mouse model of glaucoma would be interesting to
conﬁrm our ﬁndings.
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